Clinical Trials Directory

Trials / Conditions / Malignant Ovarian Mixed Epithelial Tumor

Malignant Ovarian Mixed Epithelial Tumor

8 registered clinical trials studyying Malignant Ovarian Mixed Epithelial Tumor.

StatusTrialSponsorPhase
WithdrawnAcetyl-L-Carnitine Hydrochloride in Preventing Peripheral Neuropathy in Patients With Recurrent Ovarian Epithe
NCT01492920
Gynecologic Oncology GroupPhase 3
CompletedTLR8 Agonist VTX-2337 and Pegylated Liposomal Doxorubicin Hydrochloride or Paclitaxel in Treating Patients Wit
NCT01294293
Gynecologic Oncology GroupPhase 1
CompletedA6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Prim
NCT00939809
Gynecologic Oncology GroupPhase 2
CompletedCisplatin and Paclitaxel in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Ovarian Epithe
NCT00814086
Gynecologic Oncology GroupPhase 1
TerminatedYKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal
NCT00899093
Gynecologic Oncology Group—
CompletedCarboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian
NCT00262847
National Cancer Institute (NCI)Phase 3
CompletedPolyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopia
NCT00060359
Gynecologic Oncology GroupPhase 1
TerminatedCombination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian
NCT00004221
Gynecologic Oncology GroupPhase 2